BusinessActinium Pharmaceuticals Reminds Investors of Record Date for Rights OfferingBy Nasdaq OMXFeb 7, 2018, 2:01 PM UTC
BusinessActinium Pharmaceuticals Announces Trial to Study Actimab-A in Combination with CLAG-M for Relapsed or Refractory AML PatientsBy Nasdaq OMXFeb 6, 2018, 12:30 PM UTC
BusinessCapricor Receives FDA Regenerative Medicine Advanced Therapy (RMAT) Designation for Duchenne Muscular Dystrophy TherapyBy Nasdaq OMXFeb 5, 2018, 4:11 PM UTC
BusinessBioCorRx Completes Pre-IND Meeting with FDA; Reports Company to Move Forward with BICX102By Nasdaq OMXJan 26, 2018, 12:30 PM UTC
BusinessAXIM Biotech Announces Successful Completion of Exploratory Meeting with the Dutch Medicines Evaluation Board on MedChew Rx Program for Treatment of Pain and Spasticity in MS PatientsBy Nasdaq OMXJan 23, 2018, 2:02 PM UTC
BusinessLexington Completes IRB Submission in Preparation for Clinical StudyBy Nasdaq OMXJan 18, 2018, 2:01 PM UTC
BusinessVitality Biopharma Submits Orphan Drug Designation Request to FDA for Flagship THC Prodrug VITA-100By Nasdaq OMXJan 17, 2018, 1:01 PM UTC
